Skip to main content
Log in

Changes in peritoneal permeability due to chemical fibrosis

  • Original Article
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

A relation between the mass transfer area coefficient (MTAC) and development of chemically induced fibrosis was evaluated. 20ml/kg of 0.08–0.2wt% chlorhexidine gluconate (CHG) was injected into the abdominal space of male Wistar rats (at 8 weeks). After 1–2h dwell, CHG was discarded and then the abdominal space was flushed with 20ml/kg of 0.9% saline solution three times. A peritoneal equilibration test (PET) was carried out every week for 1 month using Lactate Ringer solution containing 100 mg/dl of urea-N, 10 mg/dl of creatinine, and 1.5% of albumin. Eight out of 11 rats survived, 5 out of 8 rats developed adhesions, and 1 developed sclerosing encapsulating peritonitis-like degeneration. Although there was no statistically significant change in MTAC, MTAC increased from 1.18±0.66 ml/min to 1.92±0.6 ml/min in the first 3 weeks (P=0.09), and slightly decreased at the fourth week. It can be concluded that increase of MTAC may be due to increase of peritoneal permeability and/or increase of effective surface area such as angiogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gandhi VC, Humaayan HM, Ing TS, Daugirdas JT, Geis WP, Hano JE. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980;140:1201–1203

    Article  PubMed  CAS  Google Scholar 

  2. Nomoto Y, Kawaguchi Y, Sakai S, Hirano H, Kubo H, Ohira S, Kuriyama S, Hara S, Kubota M, Omata M, Nakao T, Honda M, Kumano K, Shimomura A, Mori N, Nishitani H, Shirai D, Imada A, Yoshino Y, Nakamoto M, Fukui H, Kurokawa K. Sclerosing encapsulating peritonitis (SEP) in patients with continuous ambulatory peritoneal dialysis—definition, diagnosis and treatment recommendations, 1995 update. J Jpn Soc Dial Ther 1996;29(2):155–163

    Google Scholar 

  3. Nomoto Y, Kawaguchi Y, Sakai S, Hirano H, Kubo H, Ohira S, Honma S, Yamagata K, Miura Y, Kimura Y, Kuriyama S, Hara S, Hamada C, Sanaka T, Nakao T, Honda M, Yokota S, Suga T, Mori N, Shimomura A, Kim M, Imada A, Tanaka R, Kawanishi H, Edakuni S, Fukui H, Nakamoto M, Kurokawa K. Sclerosing encapsulating peritonitis (SEP) in patients with continuous ambulatory peritoneal dialysis—definition, diagnosis and treatment recommendations, 1997 update. J Jpn Soc Dial Ther 1998;31(4):303–311

    Google Scholar 

  4. Suga H, Teraoka S, Ota K, Komemushi S, Furutani S, Yamauchi S, Margolin SB. Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats. Ext Toxic Pathol 1995;47:259–263

    Google Scholar 

  5. Topley N, Williams JD. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 1994;46(Suppl):S71-S78

    Google Scholar 

  6. Mackenzie RK, Coles GA, Williams JD. The response of human peritoneal macrophages to stimulation with bacteria isolated from episodes of continuous peritoneal dialysis-related peritonitis. J Infect Dis 1991;163:837–842

    PubMed  CAS  Google Scholar 

  7. Zemel D, Koomen GCM, Hart AAM, Ten Berge RJM, Strujk DG, Krediet RT. Relationship of TNFα, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 1993;122:686–696

    PubMed  CAS  Google Scholar 

  8. Hylander B, Brauner A, Wretlind B. Inflammatory factors (TNFα, IL-1β, IL-1ra) during peritonitis in CAPD patients (abstract) Perit Dial Int 1994;14:48

    Google Scholar 

  9. Topley N, Jorres A, Luttmann W, Petersen MM, Lang MJ, Thierauch KH, Muller C, Coles GA, Davies M, Williams JD. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1β and TNFα. Kidney Int 1993;43:226–233

    PubMed  CAS  Google Scholar 

  10. Goldman M, Vandenabeele P, Moulart J, Amraoui Z, Abramowicz D, Nortier J, Vanherweghem JL, Fiers W. Intraperitoneal secretion of interleukin-6 during continous ambulatory peritoneal dialysis. Nephron 1990;56:277–280

    Article  PubMed  CAS  Google Scholar 

  11. Nakahama H, Tanaka Y, Shirai D, Miyazaki M, Imai N, Yokokawa T, Okada M, Kubori S. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients. Nephron 1992;61:132–134

    Article  PubMed  CAS  Google Scholar 

  12. Brauner A, Hylander B, Wretlind B. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kid Dis 1993;22:430–435

    PubMed  CAS  Google Scholar 

  13. Watanabe S, Iwanaga S, Sato J, Ishii T, Kimura Y, Watanabe R, Kawamoto S, Kawaguchi Y, Hosoya T. Changes in interleukin-6 (IL-6) level in peritoneal effluent and peritoneal functions. Proc 43rd Congr Jpn Soc Dial Ther 1998:670

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takashi Horiuchi DEng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayashi, K., Ohta, Y., Kumano, K. et al. Changes in peritoneal permeability due to chemical fibrosis. J Artif Organs 1, 76–79 (1998). https://doi.org/10.1007/BF02479988

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02479988

Key words

Navigation